Navigation Links
ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, 2007 at 3:00 p.m. at the Mandarin Oriental Hotel in New York, NY. A live audio webcast of the presentation will be available on the Investor Information section of the ViaCell website at http://www.viacellinc.com. A replay of the presentation will be available for approximately three months after the webcast.

About ViaCell

ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord(R), a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases. ViaCell also conducts research and development primarily to investigate other potential therapeutic uses of umbilical cord blood-derived stem cells and on technology for expanding populations of these cells. ViaCell's pipeline is focused in the areas of cancer, cardiac disease, diabetes and fertility. For more information about ViaCell, visit our website at http://www.viacellinc.com. ViaCell(R) and ViaCord(R) are registered trademarks of ViaCell, Inc.

Contact

ViaCell, Inc.
Justine E. Koenigsberg, 617-914-3494
Senior Director, Corporate Communications


'"/>




Page: 1

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
9. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2018)... ... 2018 , ... Ensurem, LLC, an innovative technology and digital ... launch of the first 100 percent digital application for Medicare Supplement insurance. The ... the insurance industry. , The e-application offers consumers the ease and convenience of ...
(Date:10/17/2018)... , ... October 17, 2018 , ... ... has recently published a new technique documenting the use of placental based growth ... implants. According to Dr. Holtzclaw, “At our DIA Dental Implant Center locations ...
(Date:10/17/2018)... ... October 17, 2018 , ... The OMNISteth™ ... your video conferencing platform and intuitive adjustments maximize the sound quality and performance ... desired auscultation area on the body, which automatically adjusts the listening frequency range ...
Breaking Medicine Technology:
(Date:10/17/2018)... ... , ... A new report from The Fenway Institute and ... management of lesbian, bisexual, gay, transgender, questioning, and intersex (LGBTQI) youth in juvenile ... justice system, especially lesbian and bisexual girls and youth of color. It also ...
(Date:10/16/2018)... ... 16, 2018 , ... CCC ( Compressor Controls Corporation ) ... today announces Total Train Comprehensive Release version 14.1 (TTCR 14.1), available for immediate ... on improving cybersecurity defense around turbomachinery. The upgrade process is seamless, without ...
(Date:10/16/2018)... ... October 16, 2018 , ... With a petition (case ... of Graves McLain PLLC joins a series of lawsuits filed in states around the ... occurring at Massage Envy locations by Massage Envy’s massage therapists. , This lawsuit ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... of its mission to provide simple, easy-to-use software for biopharma companies. By pairing ... now quickly answer those crucial resourcing questions without spending millions of dollars implementing ...
(Date:10/16/2018)... (PRWEB) , ... October 16, 2018 , ... ... 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual FDA ... year’s Inspections Summit that it sometimes feels difficult to keep up. The FDA ...
Breaking Medicine News(10 mins):